VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,791,791 | -33.6% | 646,248 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $4,204,895 | -2.1% | 638,072 | +0.9% | 0.00% | 0.0% |
| Q1 2023 | $4,293,704 | -12.6% | 632,357 | -4.9% | 0.00% | -50.0% |
| Q4 2022 | $4,914,609 | -22.9% | 665,035 | +3.1% | 0.00% | 0.0% |
| Q3 2022 | $6,372,000 | -7.9% | 644,856 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $6,916,000 | -10.0% | 634,478 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $7,684,000 | -30.8% | 679,382 | -3.9% | 0.00% | -33.3% |
| Q4 2021 | $11,098,000 | +1.2% | 707,292 | +10.5% | 0.00% | -25.0% |
| Q3 2021 | $10,968,000 | -8.1% | 639,882 | +15.3% | 0.00% | 0.0% |
| Q2 2021 | $11,937,000 | +93.4% | 554,907 | +35.1% | 0.00% | +100.0% |
| Q1 2021 | $6,172,000 | +31.8% | 410,857 | +15.3% | 0.00% | 0.0% |
| Q4 2020 | $4,682,000 | +36.7% | 356,282 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $3,425,000 | -15.8% | 354,551 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $4,067,000 | +19.5% | 355,474 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $3,404,000 | -51.1% | 328,501 | -22.6% | 0.00% | -50.0% |
| Q4 2019 | $6,966,000 | -0.8% | 424,475 | -19.7% | 0.00% | 0.0% |
| Q3 2019 | $7,020,000 | +9.6% | 528,578 | +16.2% | 0.00% | 0.0% |
| Q2 2019 | $6,408,000 | -20.2% | 454,759 | +4.2% | 0.00% | -20.0% |
| Q1 2019 | $8,029,000 | -15.6% | 436,312 | +19.8% | 0.01% | -28.6% |
| Q4 2018 | $9,517,000 | +1.8% | 364,191 | -10.6% | 0.01% | +16.7% |
| Q3 2018 | $9,346,000 | +25.2% | 407,218 | +3.9% | 0.01% | +20.0% |
| Q2 2018 | $7,467,000 | +15.9% | 391,939 | +2.6% | 0.01% | 0.0% |
| Q1 2018 | $6,440,000 | -12.1% | 382,137 | -20.7% | 0.01% | -16.7% |
| Q4 2017 | $7,327,000 | -13.4% | 482,012 | +2.0% | 0.01% | -14.3% |
| Q3 2017 | $8,459,000 | +12.6% | 472,516 | +2.5% | 0.01% | 0.0% |
| Q2 2017 | $7,513,000 | +20.7% | 460,869 | +3.6% | 0.01% | +16.7% |
| Q1 2017 | $6,226,000 | -10.1% | 444,686 | +2.4% | 0.01% | -25.0% |
| Q4 2016 | $6,928,000 | +5.1% | 434,303 | +9.7% | 0.01% | 0.0% |
| Q3 2016 | $6,589,000 | +88.0% | 395,965 | +26.5% | 0.01% | +100.0% |
| Q2 2016 | $3,504,000 | +39.6% | 313,088 | +4.3% | 0.00% | +33.3% |
| Q1 2016 | $2,510,000 | +0.4% | 300,179 | +11.7% | 0.00% | 0.0% |
| Q4 2015 | $2,501,000 | +197.4% | 268,633 | +260.3% | 0.00% | +200.0% |
| Q3 2015 | $841,000 | -11.2% | 74,553 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $947,000 | +36.5% | 74,553 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $694,000 | -21.0% | 74,553 | +21.7% | 0.00% | 0.0% |
| Q4 2014 | $878,000 | +38.1% | 61,253 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $636,000 | -17.0% | 61,253 | +29.5% | 0.00% | 0.0% |
| Q2 2014 | $766,000 | -0.4% | 47,300 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $769,000 | +31.0% | 47,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $587,000 | +12.7% | 47,300 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $521,000 | +64.9% | 47,300 | +25.8% | 0.00% | 0.0% |
| Q2 2013 | $316,000 | – | 37,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |